BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity | Zendy

EuiJun Kim | Zendy; Peng Liu | Zendy; Shengjie Zhang | Zendy; Kristine Donahue | Zendy; Yidan Wang | Zendy; Jennifer L. Schehr | Zendy; Serena K. Wolfe | Zendy; Amber Dickerson | Zendy; Li Lü | Zendy; Lixin Rui | Zendy; Xuehua Zhong | Zendy; Kari B. Wisinski | Zendy; Min Yu | Zendy; Aussie Suzuki | Zendy; Joshua M. Lang | Zendy; Irene M. Ong | Zendy; Wei Xu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity

Author(s) -

EuiJun Kim,

Peng Liu,

Shengjie Zhang,

Kristine Donahue,

Yidan Wang,

Jennifer L. Schehr,

Serena K. Wolfe,

Amber Dickerson,

Li Lü,

Lixin Rui,

Xuehua Zhong,

Kari B. Wisinski,

Min Yu,

Aussie Suzuki,

Joshua M. Lang,

Irene M. Ong,

Wei Xu

Publication year - 2021

Publication title -

nucleic acids research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 9.008

H-Index - 537

eISSN - 1362-4954

pISSN - 0305-1048

DOI - 10.1093/nar/gkab1122

Subject(s) - biology , cancer research , metastasis , methylation , epigenetics , dna methylation , immune system , cancer , cancer cell , immunology , gene , gene expression , genetics

Subunits of the chromatin remodeler SWI/SNF are the most frequently disrupted genes in cancer. However, how post-translational modifications (PTM) of SWI/SNF subunits elicit epigenetic dysfunction remains unknown. Arginine-methylation of BAF155 by coactivator-associated arginine methyltransferase 1 (CARM1) promotes triple-negative breast cancer (TNBC) metastasis. Herein, we discovered the dual roles of methylated-BAF155 (me-BAF155) in promoting tumor metastasis: activation of super-enhancer-addicted oncogenes by recruiting BRD4, and repression of interferon α/γ pathway genes to suppress host immune response. Pharmacological inhibition of CARM1 and BAF155 methylation not only abrogated the expression of an array of oncogenes, but also boosted host immune responses by enhancing the activity and tumor infiltration of cytotoxic T cells. Moreover, strong me-BAF155 staining was detected in circulating tumor cells from metastatic cancer patients. Despite low cytotoxicity, CARM1 inhibitors strongly inhibited TNBC cell migration in vitro, and growth and metastasis in vivo. These findings illustrate a unique mechanism of arginine methylation of a SWI/SNF subunit that drives epigenetic dysregulation, and establishes me-BAF155 as a therapeutic target to enhance immunotherapy efficacy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research